237 related articles for article (PubMed ID: 25978633)
1. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.
Edvardsen K; Bjånesøy T; Hellesen A; Breivik L; Bakke M; Husebye ES; Bratland E
J Interferon Cytokine Res; 2015 Oct; 35(10):759-70. PubMed ID: 25978633
[TBL] [Abstract][Full Text] [Related]
2. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.
Bratland E; Hellesen A; Husebye ES
Mol Cell Endocrinol; 2013 Jan; 365(1):75-83. PubMed ID: 22989785
[TBL] [Abstract][Full Text] [Related]
3. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.
Hellesen A; Edvardsen K; Breivik L; Husebye ES; Bratland E
Clin Exp Immunol; 2014 Jun; 176(3):351-62. PubMed ID: 24666275
[TBL] [Abstract][Full Text] [Related]
4. Serum IFN-γ-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions.
Wang F; Cai R; He D; Zhao Y; Ye Y; Zhang X
Asian Pac J Allergy Immunol; 2016 Sep; 34(3):236-241. PubMed ID: 27001652
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease--an association study and expression analysis.
Fichna M; Żurawek M; Bratland E; Husebye ES; Kasperlik-Załuska A; Czarnocka B; Januszkiewicz-Lewandowska D; Nowak J
Autoimmunity; 2015 Mar; 48(2):100-7. PubMed ID: 25347332
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.
Rotondi M; Falorni A; De Bellis A; Laureti S; Ferruzzi P; Romagnani P; Buonamano A; Lazzeri E; Crescioli C; Mannelli M; Santeusanio F; Bellastella A; Serio M
J Clin Endocrinol Metab; 2005 Apr; 90(4):2357-63. PubMed ID: 15657375
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease.
Bellastella G; Rotondi M; Pane E; Costantini S; Colella C; Calemma R; Capone F; Falorni A; Castello G; Sinisi AA; Bizzarro A; Chiovato L; Bellastella A; De Bellis A
J Endocrinol Invest; 2011 Dec; 34(11):831-4. PubMed ID: 21169727
[TBL] [Abstract][Full Text] [Related]
8. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
9. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
10. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
11. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
Front Immunol; 2021; 12():688753. PubMed ID: 34276678
[TBL] [Abstract][Full Text] [Related]
13. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons.
Erridge C; Gracey J; Braund PS; Samani NJ
J Am Coll Cardiol; 2013 Oct; 62(15):1376-81. PubMed ID: 23933542
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
15. Altered chemokine Th1/Th2 balance in Addison's disease: relationship with hydrocortisone dosing and quality of life.
Ekman B; Alstrand N; Bachrach-Lindström M; Jenmalm MC; Wahlberg J
Horm Metab Res; 2014 Jan; 46(1):48-53. PubMed ID: 23918683
[TBL] [Abstract][Full Text] [Related]
16. Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.
Fluhr H; Seitz T; Zygmunt M
Breast Cancer Res Treat; 2013 Jan; 137(1):109-18. PubMed ID: 23160925
[TBL] [Abstract][Full Text] [Related]
17. Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling.
Sung PS; Lee EB; Park DJ; Lozada A; Jang JW; Bae SH; Choi JY; Yoon SK
Clin Mol Hepatol; 2018 Sep; 24(3):302-310. PubMed ID: 29526079
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
19. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
20. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
Lehtonen A; Matikainen S; Julkunen I
J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
